Patients who are interested in
more information should consult their physicians about Accumin, or go
to www.

impotence bladder

That is why major nephrology and cardiology
organizational guidelines recommended testing among at-risk groups. Offering Accumin to physicians keeps us on the
cutting edge of patient healthcare which is the very foundation of our
company's core values. The production of
testosterone can be reduced either surgically, with the removal of the
testicles, or through drugs that affect production of testosterone.

extracorporeal muljibhai

Published
studies have shown Accumin can detect abnormal levels of albumin in
urine up to 12 years earlier than conventional urine albumin testing.

bph impotence

According to the American Society of Nephrology, 18. "There is substantial evidence that albumin in the urine
is a critically important warning sign for kidney and heart disease
complications.
The progression of prostate cancer is usually driven by male sex
hormones (androgens) such as testosterone. Therefore, Teverelix LA can also
reduce testosterone levels to the low end of the normal range,
avoiding a chemical castration and its related symptoms. Ardana has marketing and manufacturing rights in Europe
for another product , Invicorp, an injectable combination of drug
treatment for erectile dysfunction.

enlargement contraindications

co.

circumcision penis

Clinical studies show that if
detected in its early stages, severe kidney disease can be slowed,
halted and in some cases reversed with common drug therapies."
"Bostwick Laboratories is committed to providing the most accurate
diagnostic tests for physicians and patients nationally," said Janet
Johnston , Director of Advanced Cytodiagnostics for Bostwick
Laboratories."

About Accumin(TM) Total Intact Albumin Assay(TM)

Cleared by the U.ausambiotech.

AusAm is a biotechnology research and development company
commercializing both diagnostic and therapeutic products to identify
and treat major diseases.

oros urology

com

About AusAm Biotechnologies, Inc.

Business Editors/Health/Medical Writers
Euro-Biotech Forum 2005

PARIS----Ardana plc (LSE:ARA) today
announced that it will be presenting at 10.ardana.

enlargement foreskin

----

Accumin Provides Only Direct Measurement of Urine Protein called
Albumin

Bostwick Laboratories today announced it will offer the
Accumin(TM) Total Intact Albumin Assay(TM) for detection of the
protein albumin in urine.6 million
Americans currently have diabetes with up to 21 percent of those
people developing kidney disease. The
American Heart Association says that around 58 million Americans have
some sort of heart disease and a study published in the Journal of the
American Medical Association (JAMA.

Ardana to Present at the Windhover Euro -Biotech Forum 2005

It is widely accepted that
reducing levels of these hormones in advanced disease can help slow
the growth of the cancer and prolong survival.
The Phase II studies have confirmed that Teverelix LA can attain and
maintain suppression of testosterone to castration levels in patients
with advanced prostate cancer.

urologic muljibhai

With Accumin, the potential for false negative results is reduced as
compared to conventional commercial assays that fail to detect all
intact albumin in the urine . BPH
is characterised by an enlargement of the prostate gland, which
results in urinary flow problems such as hesitancy, weak or
interrupted stream, urgency and more frequent urination, especially at
night.

maywood erectile

com

About Bostwick Laboratories

Bostwick Laboratories is a pathology reference laboratory
providing premium service to physicians, patients and managed care
organizations.
Ardana plc, the emerging pharmaceutical company focused on the
discovery, development and marketing of innovative products to improve
human reproductive health, is developing a broad portfolio for the
treatment of a range of reproductive indications. This makes it
suitable for clinical development in benign as well as malignant
indications.

contraindications urinary

Business Editors/Medical Editors

GLEN ALLEN, Va.

Ardana completed its IPO on the London Stock Exchange in March
2005, raising GBP 21 million and actively pursues product and
technology in-licensing and outlicensing to maintain a robust
pipeline .

overactive bph

Accumin
offers an accurate detection method that is backed by multiple
peer-reviewed studies ., and are pleased that Bostwick Laboratories will join the growing
list of laboratories currently offering this superior diagnostic
test.
For further information please see www.

impotence penis

The test provides the only direct,
quantitative reading of intact urinary protein. 2001 Jul 25;286(4):421-6) found
that "any degree of albuminuria is a risk factor for CV events in
individuals with or without diabetes mellitus (DM). "We are
striving to make Accumin the most widely available albumin test in the
U.S. Food and Drug Administration in August 2003
for the early detection of albumin as an indicator of potential kidney
disease, Accumin recently received expanded indications for use for
those at-risk for heart disease complications.

urological bladder

Bostwick Laboratories Offers Accumin Urine Albumin Test to Indicate Risk for Complications from Heart and Kidney Disease

Ardana's lead product, Teverelix LA, is in development for three
initial indications: prostate cancer, BPH and endometriosis . The growth of prostatic tissue is driven by male sex hormones,
primarily testosterone and its more potent metabolite
dihydrotestosterone (DHT).

ditropan overactive

Abnormal levels of
urinary albumin, a condition known as microalbuminuria, can indicate
elevated risk for developing cardiovascular and kidney disease
complications.

monitored mpuh

Accumin is currently offered by
several reference laboratories and hospitals in the United States
including Quest Diagnostics Incorporated, Esoterix, Millennium
Diagnostics and Specialty Laboratories. Bostwick focuses on diagnosis of cancer of
urologic organs (prostate, urinary bladder, kidney and testis) with a
special interest in prostate cancer.00 am at the Windhover
Euro -Biotech Forum 2005 on 2 June 2005, taking place at the Le
Meridien Montparnasse Hotel, Paris.

penis maywood

"Bostwick Laboratories is well known for its leadership in the
diagnosis of kidney and other urological conditions," said James R.S. In clinical studies,
Teverelix LA has been shown to decrease testosterone and subsequently
DHT in a dose-dependent manner.

extracorporeal circumcision

David Bostwick, the company's Founder and CEO, added "We are
very excited about the addition of Accumin to our testing. Teverelix
LA has successfully completed two Phase II trials in prostate cancer. Reducing levels of these hormones can
reduce the size and growth of the prostate.

muljibhai nephrology

Bostwick Laboratories will begin offering Accumin in
April 2005 .

genitourinary erectile

A positive finding of
microalbuminuria with Accumin warrants further testing.

urological erectile

nephrology muljibhai

As with other albumin assays, repeated
measurements of excretion rates over time are appropriate because of
high variability of albumin excretion.
Teverelix LA has also successfully completed a Phase II study in
Benign Prostatic Hyperplasia.

bph muljibhai

"
Dr.
McCullough, Chief Executive Officer of AusAm Biotechnologies. Accumin was developed
by AusAm Biotechnologies as a step-change improvement over
conventional tests for urine albumin. The lab's mission is to help physicians and patients
make informed treatment decisions when faced with the diagnosis of
cancer and other urologic diseases by providing the best in technical
and scientific expertise.
The company already has one product on the market, Striant(TM) SR,
a testosterone-replacement therapy that has been launched by Ardana
through its own sales force in the UK as a treatment for men with
hypogonadism.uk

nephrology requisites

Accumin(TM), AusAm's recently FDA-cleared
diagnostic for the detection of intact albumin in urine , is the first
direct test to measure a potential indicator of the beginning stages
of kidney disease and heart disease complications. For additional
information, please contact AusAm at 212-659-0703 or email inquiries
to info@ausambiotech. BPH is a common benign disease occurring
in men over the age of 50, and increases in prevalence with age.

penis overactive

"
Accumin detects albumin and permits measurement of intact albumin
not identified by current antibody and dye-binding tests.